Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum

CareDx Symposium Addresses Barriers in Access to Transplantation

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will showcase its digital health portfolio and host a symposium which addresses barriers in access to transplantation at the 31st Annual UNOS Transplant Management Forum (TMF) taking place May 16-18 in Denver, Colorado. CareDx is the leading Diamond level sponsor of this year’s UNOS TMF.

"Improving the transplant journey is at the heart of everything we do, and we are thrilled to showcase how our investment in cutting-edge digital health solutions is making a meaningful impact across the board with ever-increasing adoption,” said Kashif Rathore, Chief of Patient and Digital Solutions at CareDx. “CareDx is proud to participate in this important yearly forum to demonstrate how our connected set of transplant management solutions enables more cohesive care in the complex transplant ecosystem.”

CareDx will be hosting an interactive symposium, “Increasing Access to Transplant While Managing the Chaos.” This session, led by distinguished specialist Koren Axelrod, Director of Quality at CareDx, will be held May 16 from 12:45pm to 1:30pm MDT, covering the following topics:

  • Identifying external and internal barriers limiting transplant access to patients
  • Recognizing the impact of increased transplant access on centers
  • Digital solutions and partnership development tools (with referring providers, patients and others) to manage this impact

CareDx will be on hand to display its industry-leading suite of innovative transplant management solutions, enabling more cohesive care and efficiency across the transplant pre- and post-transplant journey.

"By leveraging the power of CareDx’s integrated digital health solutions, we're transforming the way we deliver care, streamlining operational workflows, improving quality metrics, and providing greater access to healthcare services,” said Emilie Burgess, LMSW, Director, Solid Organ Transplant, Medical City Dallas, Medical City Children’s Hospital. “Furthermore, with these tools, we're also empowering patients to have greater control of their experience, while also giving them a more efficient, effective, and personalized healthcare experience."

CareDx’s suite of digital health solutions include the AlloCare® mobile health app which is fully integrated with AlloHome® remote patient monitoring and TxAccess® to help track biometrics and better manage the transplant waitlist process, medication adherence, and ongoing education. These digital solutions along with MedActionPlan® PRO streamline communications, facilitate earlier interventions, and empower patients to take greater control of their care. The Transplant Pharmacy provides individualized transplant pharmacy services to help facilitate medication adherence and education, and Ottr® and TransChart® help centers manage transplant workflows to achieve clinical efficiencies, and through the use of XynQAPI® improvements in quality of care and patient outcomes. CareDx also offers HLA Data Systems mTilda, a leading lab information management software (LIMS) for human leukocyte antigen (HLA) laboratories.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Forward Looking Statements

This press release includes forward-looking statements related to CareDx, Inc., including statements regarding the potential benefits and results that may be achieved with CareDx’s digital health portfolio, as well as CareDx’s leading participation at the 31st annual UNOS Transplant Management Forum (the “Participation”). These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks that CareDx does not realize the expected benefits of its digital health portfolio or Participation; general economic and market factors; and other risks discussed in CareDx’s filings with the SEC, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed by CareDx with the SEC on February 27, 2023, the quarterly report on Form 10-Q for the quarter ended March 31, 2023 filed by CareDx with the SEC on May 10, 2023, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx’s actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx’s forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.